Evidence map›Paper›PMID 41438395›Full record

ArticleInternational journal of reproductive biomedicine2025

Fetus-in-fetu, a rare congenital anomaly: A case report.

Vida Radi, Nasrin Mohammadi

Abstract readCase Reports
In one paragraph

Article in International journal of reproductive biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vida RadiDepartment of Gynecology and Obstetrics, Bentolhoda Hospital, North Khorasan University of Medical Sciences, Bojnord, Iran.
Nasrin MohammadiDepartment of Gynecology and Obstetrics, Bentolhoda Hospital, North Khorasan University of Medical Sciences, Bojnord, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fetus-in-fetu (FIF) is an extremely rare congenital anomaly characterized by the development of a parasitic fetus within the body of its twin. This condition typically results from abnormal embryogenesis in a monochorionic diamniotic pregnancy. Its incidence is estimated to be approximately 1 in 500,000 live births, with fewer than 200 cases reported in medical literature. Case Presentation: We report the case of a 21-yr-old pregnant woman at 35 wk and 1 day of gestation, confirmed by first trimester ultrasound. The nuchal translucency screening was delayed due to the patient's late presentation. Her obstetric history included a normal vaginal delivery 2 years prior, resulting in a healthy full-term female infant. Neither the patient nor her spouse reported any significant medical history, genetic disorders, or hereditary diseases. The patient had received routine prenatal care, including folic acid supplementation from conception and one dose of COVID-19 vaccine. She did not receive specialized high-risk obstetric care and was managed with standard prenatal services at a primary healthcare center. Her initial consultation with a gynecologist occurred on October 14, 2024, when the FIF diagnosis was established. All laboratory investigations were within normal limits. Conclusion: FIF represents a rare yet clinically significant condition that requires high clinical suspicion for accurate and timely diagnosis. Differentiating FIF from mature cystic teratoma is crucial, as their therapeutic approaches and prognostic outcomes differ substantially. Reporting new cases can enhance our understanding of its pathogenesis and contribute to improved patient outcomes.

Indexed as

Clinical case.Congenital anomalyFetus-in-fetuTeratomaTwin

Identifiers

PMID41438395
PMCPMC12703025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.